Protein map using MS-based analysis shared in open database
Study using mass spectrometry-based analysis provides a greater understanding of the cell and a comprehensive map of cell proteins...
List view / Grid view
Study using mass spectrometry-based analysis provides a greater understanding of the cell and a comprehensive map of cell proteins...
A complete workflow to quantify intact therapeutic proteins in plasma matrix has been developed, covering three critical components in preclinical sample analysis: target protein enrichment/purification, LC/MS data acquisition and quantitative data analysis.
The rapid increase in demand for biopharmaceuticals presents manufacturers with unique challenges to ensure quality and regulatory compliance while maintaining supply and production capacity.
Dr Lazar’s team identified that TZDs, while working for PPAR gamma, promoted the metabolism of glutamine, an amino acid...
Shimadzu, one of the world's fastest growing mass spectrometry companies and Protein Metrics Inc., a leading provider of mass spectrometry software for protein characterisation, today announced a co-marketing agreement for the use of Byos™ with Shimadzu Q-TOF technology...
Researchers have identified exterior proteins on the bacteria that could serve as vaccine targets for syphilis.
Supports development of analytical workflows to generate precise molecular profiles of patients...
Researchers have developed a new biotech technique that promises to accelerate research into protein therapies...
A group of researchers is showing how artificial intelligence approaches can help identify cause-effect relationships within data...
New technology could lead to the development of new cancer therapies...
Researchers at the TAT (Targeted Anticancer Therapies) International Congress 2018 in Paris have presented new epigenetics compounds that show early activity in lymphoma patients.
An international team of researchers has developed a computational resource that provides a 3D view of genes, proteins and metabolites involved in human metabolism...
An international team of researchers has identified the key role that IL-18 protein plays in Still’s disease, making it a prime candidate for IL-18 inhibitor drug that is proving promising in current trials.
International researchers believe that their new blood and urine tests which search for damage to proteins are the first of their kind to detect early autism spectrum disorders...
Technical advances in vaccine production should shorten the time to clinical trials, breaking the logjam of promising new candidate vaccines waiting to be tested...